SCHEMBL1008667

SCHEMBL1008667

CN(C)S(=O)(=O)C(F)(F)F

nearest known ligand 0.37

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.37
CA2 P00918 3/20 0.37
CA7 P43166 1/20 0.37
CA13 Q8N1Q1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2058155 0.81 CA1 (0.33) CA1CA2CA7CA13
SCHEMBL25309127 0.81
SCHEMBL4754969 0.80 CA1 (0.37) CA1CA2CA7CA13
SCHEMBL7925588 0.80 CA1 (0.30) CA1CA2CA7CA13
SCHEMBL6437203 0.78 CA1 (0.35) CA1CA2CA7CA13
SCHEMBL4366853 0.77
SCHEMBL4078286 0.76
SCHEMBL24465429 0.75 CA1 (0.40) CA1CA2CA7CA13
SCHEMBL17878817 0.75 CA1 (0.33) CA1CA2CA7CA13
SCHEMBL24667270 0.73 CA1 (0.32) CA1CA2CA7CA13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 206 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026106777-A1 BATTERY COMPOSITIONS USING BIOGENIC ANODE MATERIALS ELEMENTIUM MATERIALS, INC. (US) 2026-05-21 WO claimed
EP-4730463-A1 LIQUID ELECTROLYTE COMPRISING SULFONAMIDE AND AT LEAST TWO LITHIUM SALTS, AND USES THEREOF Basquevolt S.A.U. (ES) 2026-04-22 EP claimed
US-20260106224-A1 LIQUID ELECTROLYTE COMPRISING SULFONAMIDE AND AT LEAST TWO LITHIUM SALTS, AND USES THEREOF BASQUEVOLT S A (ES) 2026-04-16 US claimed
US-20260094862-A1 ELECTROLYTIC SOLUTION FOR LITHIUM METAL SECONDARY BATTERY HONDA MOTOR CO LTD (JP) 2026-04-02 US claimed
EP-4655837-A1 POLYMER ELECTROLYTE COMPOSITION Basquevolt, S.A. (ES) 2025-12-03 EP claimed
WO-2025231187-A1 LITHIUM METAL ELECTRODE AND BATTERY Pure Lithium Corporation (US) 2025-11-06 WO claimed
US-20250293306-A1 NON-AQUEOUS ELECTROLYTE SOLUTIONS TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) 2025-09-18 US claimed
EP-4576309-A1 SODIUM SECONDARY BATTERY, BATTERY MODULE, BATTERY PACK, AND ELECTRIC DEVICE Contemporary Amperex Technology (Hong Kong) Limited (HK) 2025-06-25 EP claimed
US-20250192232-A1 ELECTROLYTE FOR SECONDARY BATTERY, SECONDARY BATTERY, BATTERY MODULE, BATTERY PACK, AND ELECTRIC APPARATUS CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) 2025-06-12 US claimed
EP-4560757-A1 ELECTROLYTE FOR SECONDARY BATTERY, SECONDARY BATTERY, BATTERY MODULE, BATTERY PACK, AND ELECTRICAL DEVICE Contemporary Amperex Technology Co., Limited (CN) 2025-05-28 EP claimed
US-11680041-B1 Processes for producing high-purity N,N-dialkyl perfluoroalkylsulfonamide SES HOLDINGS PTE. LTD. (SG) 2023-06-20 US claimed
WO-2023105411-A1 PROCESSES FOR PRODUCING HIGH-PURITY N, N-DIALKYL PERFLUOROALKYL SULFONAMIDE SES HOLDINGS PTE. LTD. (SG) 2023-06-15 WO claimed
US-20230174469-A1 Processes For Producing High-Purity N,N-Dialkyl Perfluoroalkylsulfonamide SES HOLDINGS PTE. LTD. (SG) 2023-06-08 US claimed
CN-115703722-A Preparation method of N, N-dimethyl trifluoromethyl sulfonamide 江苏国泰超威新材料有限公司 2023-02-17 CN claimed
CN-115621478-A Application of non-aqueous electrolyte containing lithium chlorosulfonyl imide in primary lithium battery 华中科技大学 2023-01-17 CN claimed
WO-2022178271-A1 ULTRA-HIGH-VOLTAGE RECHARGEABLE BATTERIES WITH SULFONAMIDE-BASED ELECTROLYTES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2022-08-25 WO claimed
CN-114024025-A Copolymerization solid electrolyte, preparation method thereof and solid polymer lithium battery 华中科技大学 2022-02-08 CN claimed
CN-113921911-A Application of N, N-dimethyl trifluoromethanesulfonamide in battery electrolyte 石家庄圣泰化工有限公司 2022-01-11 CN claimed
CN-113801040-A Synthesis method of N, N-dimethyl trifluoromethanesulfonamide 石家庄圣泰化工有限公司 2021-12-17 CN claimed
US-3941453-A Birefringent compounds used in Kerr cells U.S. PHILIPS CORPORATION (US) 1976-03-02 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11680041-B1 Processes for producing high-purity N,N-dialkyl perfluoroalkylsulfonamide RFC2, AFF2, AFF1 CA1 2305/4885CA2 3249/4885CA7 2465/4885
US-20260106224-A1 LIQUID ELECTROLYTE COMPRISING SULFONAMIDE AND AT LEAST TWO LITHIUM SALTS, AND USES THEREOF LEF1, LITAF, NHERF1 CA1 191/4885CA2 141/4885CA7 903/4885
US-20230174469-A1 Processes For Producing High-Purity N,N-Dialkyl Perfluoroalkylsulfonamide RFC2, AFF2, AFF1 CA1 2305/4885CA2 3249/4885CA7 2465/4885
US-20260094862-A1 ELECTROLYTIC SOLUTION FOR LITHIUM METAL SECONDARY BATTERY MGMT, KCNN2, LSM12 CA1 471/4885CA2 85/4885CA7 760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.